Literature DB >> 30590724

Secular trends in the incidence and prevalence of gout in Denmark from 1995 to 2015: a nationwide register-based study.

Kristian Zobbe1,2, Daniel Prieto-Alhambra3,4, René Cordtz1,2, Pil Højgaard1,2, Jens Skøt Hindrup1, Lars Erik Kristensen2, Lene Dreyer1,2,5.   

Abstract

OBJECTIVE: To investigate temporal trends in the incidence and prevalence of gout in the adult Danish population.
METHODS: Using the nationwide Danish National Patient Registry, we calculated the number of incident gout patients (per 100 000 person-years) within each 1 year period from 1995 to 2015 and the prevalence of gout in 2000 and 2015. Further, we calculated age- and gender-specific incidence rates of gout from 1995 to 2015.
RESULTS: We identified a total of 45 685 incident gout patients (72.9% males) with a mean age of 65 years (s.d. 16) at diagnosis. In both genders, an increase in age-standardized incidence rates was observed from 32.3/100 000 (95% CI 30.7, 33.9) in 1995 to 57.5/100 000 (95% CI 55.6, 59.5) in 2015 (P < 0.001). Similar trends were observed for 8950 cases diagnosed in rheumatology departments. We likewise observed an increase in the prevalence of gout from 0.29% (95% CI 0.29, 0.30) in 2000 to 0.68% (95% CI 0.68, 0.69) in 2015.
CONCLUSIONS: The annual incidence rate of gout increased by almost 80% in Denmark between 1995 and 2015. The prevalence increased by nearly 130% between 2000 and 2015. Reasons for this are unknown but may include an increase in risk factors (e.g. obesity, diabetes mellitus), longer life expectancy and increased awareness of the disease among patients and/or health professionals.
© The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  crystal arthropathy; epidemiology; gout; incidence; prevalence

Year:  2019        PMID: 30590724     DOI: 10.1093/rheumatology/key390

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  7 in total

1.  Epidemiology of gout in Hong Kong: a population-based study from 2006 to 2016.

Authors:  Man Fung Tsoi; Man Ho Chung; Bernard Man Yung Cheung; Chak Sing Lau; Tommy Tsang Cheung
Journal:  Arthritis Res Ther       Date:  2020-09-04       Impact factor: 5.156

2.  Establishment of a clinical diagnostic model for gouty arthritis based on the serum biochemical profile: A case-control study.

Authors:  Shang Lyu; Ruowen Ding; Shilin Yang; Wanyuan Chen; Yi Rao; Hui OuYang; Peng Liu; Yulin Feng
Journal:  Medicine (Baltimore)       Date:  2021-04-23       Impact factor: 1.817

3.  Genetic assessment of hyperuricemia and gout in Asian, Native Hawaiian, and Pacific Islander subgroups of pregnant women: biospecimens repository cross-sectional study.

Authors:  Ali Alghubayshi; Alison Edelman; Khalifa Alrajeh; Youssef Roman
Journal:  BMC Rheumatol       Date:  2022-01-06

4.  Prevalence and Risk Factors of Hyperuricemia and Gout: A Cross-sectional Survey from 31 Provinces in Mainland China.

Authors:  Jing Song; Chenye Jin; Zhongyan Shan; Weiping Teng; Jing Li
Journal:  J Transl Int Med       Date:  2022-07-07

5.  Prevalence of hyperuricemia in patients with severe obesity and the relationship between serum uric acid and severe obesity: A decade retrospective cross-section study in Chinese adults.

Authors:  Chonin Cheang; Saikam Law; Jieru Ren; Wengtong Chan; Cunchuan Wang; Zhiyong Dong
Journal:  Front Public Health       Date:  2022-08-26

6.  Prevalence of Patients Receiving Urate-Lowering Medicine in Greenland and Denmark: A Cross-Sectional Case-Control Study.

Authors:  Sidsel Dan Hull; Marianne Welzel Andersen; Jessica Bengtsson; Nils Skovgaard; Marie Balslev Backe; Michael Lynge Pedersen
Journal:  Int J Environ Res Public Health       Date:  2022-06-13       Impact factor: 4.614

Review 7.  Dietary and Lifestyle-Centered Approach in Gout Care and Prevention.

Authors:  Chio Yokose; Natalie McCormick; Hyon K Choi
Journal:  Curr Rheumatol Rep       Date:  2021-07-01       Impact factor: 4.686

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.